Matthew Angel

Matthew Angel

Director Ejecutivo en TEMPEST THERAPEUTICS, INC. .

Fortuna: 6 M $ al 30/06/2026

45 años
Health Technology
Finance
Consumer Services

Perfil

Matthew Angel was the founder of Novellus LLC, founded in 2014, serving as Chief Science Officer from 2014 to 2021.
Dr. Angel is the founder of Exacis Biotherapeutics, Inc., founded in 2020, serving as Director & Chief Scientific Officer since 2020.
Dr. Angel is the founder of Factor Bioscience, Inc., founded in 2011, serving as Chairman & Chief Executive Officer since 2011.
Dr. Angel is President, Chief Executive Officer & Director at Tempest Therapeutics, Inc. since 2026.
Former positions include President & Chief Executive Officer at Ernexa Therapeutics, Inc. in 2023.
Education includes a doctorate from Massachusetts Institute of Technology and an undergraduate degree from Princeton University.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
28/05/2026 5.068.552 ( 37,6 % ) 6 M $ 30/06/2026

Cargos activos de Matthew Angel

EmpresasCargoInicio
TEMPEST THERAPEUTICS, INC. Director Ejecutivo 03/02/2026
Director Ejecutivo 01/01/2011
Fundador 01/01/2020

Antiguos cargos conocidos de Matthew Angel.

EmpresasCargoFin
ERNEXA THERAPEUTICS INC. Director Ejecutivo 31/12/2023
ERNEXA THERAPEUTICS INC. Director Ejecutivo 04/08/2023
Fundador 01/07/2021
Ver el detalle de la experiencia de Matthew Angel.

Formación de Matthew Angel.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

16

Relaciones de 1er grado

7

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas7

Finance

Consumer Services

Health Technology

Commercial Services

Health Services

Health Technology

Health Technology